325 related articles for article (PubMed ID: 8989248)
1. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
[TBL] [Abstract][Full Text] [Related]
2. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.
Donner H; Braun J; Seidl C; Rau H; Finke R; Ventz M; Walfish PG; Usadel KH; Badenhoop K
J Clin Endocrinol Metab; 1997 Dec; 82(12):4130-2. PubMed ID: 9398726
[TBL] [Abstract][Full Text] [Related]
3. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
Heward JM; Allahabadia A; Armitage M; Hattersley A; Dodson PM; Macleod K; Carr-Smith J; Daykin J; Daly A; Sheppard MC; Holder RL; Barnett AH; Franklyn JA; Gough SC
J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.
Badenhoop K; Walfish PG; Rau H; Fischer S; Nicolay A; Bogner U; Schleusener H; Usadel KH
J Clin Endocrinol Metab; 1995 Jul; 80(7):2112-7. PubMed ID: 7608264
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.
Kikuoka N; Sugihara S; Yanagawa T; Ikezaki A; Kim HS; Matsuoka H; Kobayashi Y; Wataki K; Konda S; Sato H; Miyamoto S; Sasaki N; Sakamaki T; Niimi H; Murata M
Clin Endocrinol (Oxf); 2001 Nov; 55(5):597-603. PubMed ID: 11894970
[TBL] [Abstract][Full Text] [Related]
6. Genetic markers in diagnosis and prediction of relapse in Graves' disease.
Badenhoop K; Donner H; Braun J; Siegmund T; Rau H; Usadel KH
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():98-100. PubMed ID: 8981012
[TBL] [Abstract][Full Text] [Related]
7. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis.
Seidl C; Donner H; Fischer B; Usadel KH; Seifried E; Kaltwasser JP; Badenhoop K
Tissue Antigens; 1998 Jan; 51(1):62-6. PubMed ID: 9459504
[TBL] [Abstract][Full Text] [Related]
9. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
[TBL] [Abstract][Full Text] [Related]
12. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes.
Ongagna JC; Sapin R; Pinget M; Belcourt A
Int J Exp Diabetes Res; 2002; 3(1):1-9. PubMed ID: 11900275
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.
Pullmann R; Lukác J; Skerenová M; Rovensky J; Hybenová J; Melus V; Celec S; Pullmann R; Hyrdel R
Clin Exp Rheumatol; 1999; 17(6):725-9. PubMed ID: 10609073
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
Yung E; Cheng PS; Fok TF; Wong GW
Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
[TBL] [Abstract][Full Text] [Related]
15. An Mse I RFLP in the human CTLA4 promotor.
Deichmann K; Heinzmann A; Brüggenolte E; Forster J; Kuehr J
Biochem Biophys Res Commun; 1996 Aug; 225(3):817-8. PubMed ID: 8780695
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].
Andreevskiĭ TV; Sudomoina MA; Gusev EI; Boĭko AN; Alekseenkov AD; Favorova OO
Mol Biol (Mosk); 2002; 36(4):643-8. PubMed ID: 12173468
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a german population.
Badenhoop K; Donner H; Pani M; Rau H; Siegmund T; Braun J
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S89-92. PubMed ID: 10522814
[TBL] [Abstract][Full Text] [Related]
18. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Kouki T; Gardine CA; Yanagawa T; Degroot LJ
J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
[TBL] [Abstract][Full Text] [Related]
19. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
[TBL] [Abstract][Full Text] [Related]
20. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.
Abe T; Yamaguchi Y; Takino H; Fujita N; Yamauchi-Degawa M; Ozaki M; Yamakawa K; Sera Y; Sakamaki H; Uotani S; Kawasaki E; Awata T; Yamasaki H; Eguchi K
Diabet Med; 2001 Sep; 18(9):726-31. PubMed ID: 11606170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
